Literature DB >> 17893159

Establishment of a UK National Influenza H5 Laboratory Network.

Martin D Curran1, Joanna S Ellis2, Tim G Wreghitt1, Maria C Zambon2.   

Abstract

Avian (H5N1) influenza continues to pose a significant threat to human health, although it remains a zoonotic infection. Sensitive and robust surveillance measures are required to detect any evidence that the virus has acquired the ability to transmit between humans and emerge as the next pandemic strain. An integral part of the pandemic planning response in the UK was the creation in 2005 of the UK National H5 Laboratory Network, capable of rapidly and accurately identifying potential human H5N1 infections in all regions of the UK, and the Republic of Ireland. This review details the challenges that designing molecular detection methods for a rapidly evolving virus present, and the strategic decisions and choices required to ensure successful establishment of a functional national laboratory network, providing round the clock testing for H5N1. Laboratory partnerships have delivered improved real-time one-step multiplex PCR methodologies to ensure streamlined testing capable of not only detecting H5 but also a differential diagnosis of seasonal influenza A/B. A range of fully validated real-time PCR H5 confirmatory assays have been developed to run in parallel with a universal first-screening assay. Regular proficiency panels together with weekly surveillance runs, intermittent on-call testing for suspect cases of avian flu in returning travellers, and several outbreaks of avian influenza outbreaks in poultry that have occurred since 2005 in the UK have fully tested the network and the current diagnostic strategies for avian influenza. The network has clearly demonstrated its capability of delivering a confirmed H5N1 diagnosis within 3-4 h of receipt of a sample, an essential prerequisite for administration of the appropriate antiviral therapy, effective clinical management, disease containment and implementation of infection control measures. A functional network is an important means of enhancing laboratory capability and building diagnostic capacity for a newly emerging pandemic of influenza, and is an essential part of pandemic preparedness.

Entities:  

Mesh:

Year:  2007        PMID: 17893159     DOI: 10.1099/jmm.0.47336-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom.

Authors:  Azra Ghani; Marc Baguelin; Jamie Griffin; Stefan Flasche; Albert Jan van Hoek; Simon Cauchemez; Christl Donnelly; Chris Robertson; Michael White; James Truscott; Christophe Fraser; Tini Garske; Peter White; Steve Leach; Ian Hall; Helen Jenkins; Neil Ferguson; Ben Cooper
Journal:  PLoS Curr       Date:  2009-11-16

2.  Establishing a laboratory network of influenza diagnosis in Indonesia: an experience from the avian flu (H5N1) outbreak.

Authors:  Vivi Setiawaty; Krisna Na Pangesti; Ondri D Sampurno
Journal:  Clin Epidemiol       Date:  2012-08-15       Impact factor: 4.790

3.  Development and implementation of the quality control panel of RT-PCR and real-time RT-PCR for avian influenza A (H5N1) surveillance network in mainland China.

Authors:  Rongbao Gao; Yan Gao; Leying Wen; Ming Shao; Shumei Zou; Changgui Li; Lei Yang; Xiyan Li; Wei Wang; Yuelong Shu
Journal:  BMC Infect Dis       Date:  2011-03-16       Impact factor: 3.090

4.  Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England.

Authors:  Nick Andrews; Pauline Waight; Chee-Fu Yung; Elizabeth Miller
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

5.  Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK.

Authors:  Monica Galiano; Paul-Michael Agapow; Catherine Thompson; Steven Platt; Anthony Underwood; Joanna Ellis; Richard Myers; Jonathan Green; Maria Zambon
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

6.  Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom.

Authors:  Richard G Pebody; Ross Harris; George Kafatos; Mary Chamberland; Colin Campbell; Jonathan S Nguyen-Van-Tam; Estelle McLean; Nick Andrews; Peter J White; Edward Wynne-Evans; Jon Green; Joanna Ellis; Tim Wreghitt; Sam Bracebridge; Chikwe Ihekweazu; Isabel Oliver; Gillian Smith; Colin Hawkins; Roland Salmon; Bryan Smyth; Jim McMenamin; Maria Zambon; Nick Phin; John M Watson
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

Review 7.  Avian influenza--a review for doctors in travel medicine.

Authors:  W R J Taylor; E Burhan; H Wertheim; P Z Soepandi; P Horby; A Fox; R Benamore; L de Simone; T T Hien; F Chappuis
Journal:  Travel Med Infect Dis       Date:  2009-12-01       Impact factor: 6.211

8.  PrimerHunter: a primer design tool for PCR-based virus subtype identification.

Authors:  Jorge Duitama; Dipu Mohan Kumar; Edward Hemphill; Mazhar Khan; Ion I Mandoiu; Craig E Nelson
Journal:  Nucleic Acids Res       Date:  2009-03-05       Impact factor: 16.971

9.  Evaluation of the Cepheid respiratory syncytial virus and influenza virus A/B real-time PCR analyte specific reagent.

Authors:  Andrew D Sails; David Saunders; Stephanie Airs; David Roberts; Gary Eltringham; John G Magee
Journal:  J Virol Methods       Date:  2009-08-03       Impact factor: 2.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.